Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C] Acetate PET/CT in ADHF
NCT03924102Phase 1Withdrawn
- Sponsor
- University of Alabama at Birmingham
- Start
- Dec 2025
- Primary completion
- Oct 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Alabama at Birmingham. Primary endpoint: Inflammation in patients with acute decompensated heart failure (ADHF) measured with rest-stress [11C] acetate PET/CT at 3 years. Planned start Dec 2025; status: withdrawn.
Beyond the preview
Go deeper on NCT03924102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03924102.